Providing Patients Hope With Right to Try (Guest: Bartley Madden)
By Sarah Lee, Bartley J. Madden
Bartley Madden, author of Free to Choose Medicine, discusses the recent signing by President Donald Trump of Right to Try legislation and the general move towards Free to Choose Medicine.
Recently, President Donald Trump signed Right to Try legislation, codifying the policy idea that terminal patients and their families should be given the freedom to decide what treatments, therapies, and drugs they're comfortable trying without waiting for the arduous approval process of the Food and Drug Administration.
Madden, a longtime proponent of Right to Try, talks about the issue as it relates to the broader effort, supported by The Heartland Institute, of giving Americans freedom to choose their health care drugs and therapies after those drugs and therapies have passed the safety, and a portion of the efficacy, phases of the FDA approval process. Madden credits Heartland President Tim Huelskamp and other libertarian and conservative-leaning organizations and individuals for bringing the issue to the attention of the Trump administration and discusses his optimism that Wednesday's signing marks the first step in the long process toward freedom of choice in health care.
Sarah Lee is a policy advisor for health care and a host of Heartland's Health Care News podcast.
slee@heartland.org
Bartley J. Madden
Bartley J. Madden retired as a managing director of Credit Suisse HOLT after a career in investment research and money management that included the founding of Callard Madden & Associates.
bartmadden@yahoo.com